Matches in SemOpenAlex for { <https://semopenalex.org/work/W34876957> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W34876957 endingPage "51" @default.
- W34876957 startingPage "648" @default.
- W34876957 abstract "To determine the optimal adenosine dose effective in supraventricular tachycardia (SVT) and underlying conditions affecting the effective dose in children.Experimental study.Department of Cardiology, The Children's Hospital and Institute of Child Health, Lahore, from July 2008 to June 2011.All children presenting with SVT were administered adenosine in rapid boluses according to PALS guidelines using incremental doses of 100, 200 and 300 μg/kg. The response was recorded on 12 lead ECG. Preexcitation was documented and echocardiography performed on all children after attaining sinus rhythm. Mann Whitney test and Kruskal-Wallis test were used as a test of significance to determine any difference in effective adenosine dose between normal heart and various underlying conditions, taking p < 0.05 as significant.Eighty five patients were treated for 110 episodes of SVT with adenosine. M:F ratio was 2.2:1. Their age ranged from 6 days to 14 years with mean age of 27.9 months. Adenosine was effective in reverting 97 episodes of SVT to sinus rhythm (88.2%). A dose of upto 100 μg/kg was only effective in 36.4% episodes of SVT. Two hundred μg/kg was effective in 44.3% of those not responding to 100 μg/kg dose (n = 31/70, cumulative 64.5%). A dose of 300 μg/kg was effective in further 25 patients not responding to lower doses (n = 25/38, 65.8%; cumulative 88.2%). Mean effective dose of adenosine was 185.3 + 81.0 μg/kg with median effective dose of 200 μg/kg. Significantly higher dose of adenosine was required in children with underlying pre-excitation, n = 18/97 (220.8 + 67.6 μg/kg vs. 177.2 + 81.9 μg/kg, p = 0.039).Adenosine is an effective medicine in treating SVT in children. A higher dose of 200 μg/kg may be used as first bolus particularly in children with pre-excitation." @default.
- W34876957 created "2016-06-24" @default.
- W34876957 creator A5021285355 @default.
- W34876957 creator A5029563363 @default.
- W34876957 creator A5041514021 @default.
- W34876957 creator A5055831835 @default.
- W34876957 date "2012-10-01" @default.
- W34876957 modified "2023-09-23" @default.
- W34876957 title "Optimal dose of adenosine effective for supraventricular tachycardia in children." @default.
- W34876957 cites W1493851469 @default.
- W34876957 cites W1912183902 @default.
- W34876957 cites W1966921828 @default.
- W34876957 cites W1991689878 @default.
- W34876957 cites W2002489198 @default.
- W34876957 cites W2004868609 @default.
- W34876957 cites W2007671697 @default.
- W34876957 cites W2014243985 @default.
- W34876957 cites W2023416167 @default.
- W34876957 cites W2026486609 @default.
- W34876957 cites W2042884068 @default.
- W34876957 cites W2052138613 @default.
- W34876957 cites W2068978696 @default.
- W34876957 cites W2109910623 @default.
- W34876957 cites W2110201936 @default.
- W34876957 cites W2114364220 @default.
- W34876957 cites W2152350310 @default.
- W34876957 cites W2896282214 @default.
- W34876957 cites W3022250925 @default.
- W34876957 cites W766942283 @default.
- W34876957 doi "https://doi.org/10.2012/jcpsp.648651" @default.
- W34876957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23058149" @default.
- W34876957 hasPublicationYear "2012" @default.
- W34876957 type Work @default.
- W34876957 sameAs 34876957 @default.
- W34876957 citedByCount "3" @default.
- W34876957 countsByYear W348769572021 @default.
- W34876957 countsByYear W348769572023 @default.
- W34876957 crossrefType "journal-article" @default.
- W34876957 hasAuthorship W34876957A5021285355 @default.
- W34876957 hasAuthorship W34876957A5029563363 @default.
- W34876957 hasAuthorship W34876957A5041514021 @default.
- W34876957 hasAuthorship W34876957A5055831835 @default.
- W34876957 hasConcept C126322002 @default.
- W34876957 hasConcept C12868164 @default.
- W34876957 hasConcept C149857219 @default.
- W34876957 hasConcept C151032500 @default.
- W34876957 hasConcept C164705383 @default.
- W34876957 hasConcept C2775914520 @default.
- W34876957 hasConcept C2776934708 @default.
- W34876957 hasConcept C2776991684 @default.
- W34876957 hasConcept C2779161974 @default.
- W34876957 hasConcept C2780283014 @default.
- W34876957 hasConcept C2989005 @default.
- W34876957 hasConcept C42219234 @default.
- W34876957 hasConcept C71924100 @default.
- W34876957 hasConceptScore W34876957C126322002 @default.
- W34876957 hasConceptScore W34876957C12868164 @default.
- W34876957 hasConceptScore W34876957C149857219 @default.
- W34876957 hasConceptScore W34876957C151032500 @default.
- W34876957 hasConceptScore W34876957C164705383 @default.
- W34876957 hasConceptScore W34876957C2775914520 @default.
- W34876957 hasConceptScore W34876957C2776934708 @default.
- W34876957 hasConceptScore W34876957C2776991684 @default.
- W34876957 hasConceptScore W34876957C2779161974 @default.
- W34876957 hasConceptScore W34876957C2780283014 @default.
- W34876957 hasConceptScore W34876957C2989005 @default.
- W34876957 hasConceptScore W34876957C42219234 @default.
- W34876957 hasConceptScore W34876957C71924100 @default.
- W34876957 hasIssue "10" @default.
- W34876957 hasLocation W348769571 @default.
- W34876957 hasOpenAccess W34876957 @default.
- W34876957 hasPrimaryLocation W348769571 @default.
- W34876957 hasRelatedWork W2004868609 @default.
- W34876957 hasRelatedWork W2033850501 @default.
- W34876957 hasRelatedWork W2050641639 @default.
- W34876957 hasRelatedWork W2064031130 @default.
- W34876957 hasRelatedWork W2067013088 @default.
- W34876957 hasRelatedWork W2093797920 @default.
- W34876957 hasRelatedWork W2140392144 @default.
- W34876957 hasRelatedWork W2279470050 @default.
- W34876957 hasRelatedWork W2341848548 @default.
- W34876957 hasRelatedWork W34876957 @default.
- W34876957 hasVolume "22" @default.
- W34876957 isParatext "false" @default.
- W34876957 isRetracted "false" @default.
- W34876957 magId "34876957" @default.
- W34876957 workType "article" @default.